Adjuvant chemoradiotherapy for high-risk pancreatic cancer

Singapore Medical Journal

Volumn 50, Issue 1, 2009, Pages 43-48

  Wang, M L C ^a   Foo, K F ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b GLENEAGLES HOSPITAL   (Singapore)

Author keywords

Adjuvant chemoradiotherapy; Chemoradiotherapy; Pancreatic cancer; Resected pancreatic cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PANCREAS CANCER; RADIATION DOSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 62649132088     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82:11-5.
2. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990; 66:51-61.
3. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165:68-73.
4. Kalser MH, Ellenberg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 123:899-903.
5. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59:2006-10.
6. Klinkenbijl JH, Jeekel J, Samouhd T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection for the cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 1999; 230:776-84.
7. Neoptolemos JP, Stocken DD, Friess H, et al. European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Eng J Med 2004; 350:1200-10.
8. Stocken DD, Buchler MW, Dervenis C, et al, Meta-analysis of randomized adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005; 92:1372-81.
9. Trends in Cancer Incidence in Singapore 1968-2002. Singapore Cancer Registry, 2004.
10. Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and in clinical beneft with Gemcitabine as frst-line therapy for patients with advanced pancreatic cancer: A randomized trial. J Clin Oncol 1997; 15:2403-13.
11. Cancer Therapy Evaluation Program. Common toxicity criteria, version 2.0. Bethesda, MD: Division of Cancer Treatment & Diagnosis, National Institute of Health, March 1998.
12. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed. Chicago, IL: Springer, 2002.
13. Abrams RA, Grochow LB, Chakravarthy A, et al. Intensifed adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 1999; 44:1039-46.
14. Regine WF, John WJ, McGrath P, et al. The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma. J Hepatobiliary Pancreat Surg 2000; 7:53-7.
15. Landry JC, Yang GY, Ting JY, et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 2002; 27:121-9.
16. Brown MW, Ning H, Arora B, et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. Int J Radiat Oncol Biol Phys 2006; 65:274-83.
17. Crane CH, Abbruzzese JL, Evans DB, et al. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 2002; 52:1293-302.
18. Lawrence TS, Change EY, Hohn TM, et al. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34:867-72.
19. Demols A, Peeters M, Polus M, et al. Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian phase II study. Int J Radiat Oncol Biol Phys 2005; 62:1351-6.
20. Blackstock AW, Mornex F, Partensky C, et al. Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer 2006; 95:260-5.
21. Murphy JD, Adusumilli S, Griffith KA, et al. Full-dose Gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2007; 68:801-8.